Walgreens EBITDA 2010-2024 | WBA

Walgreens annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Walgreens EBITDA for the quarter ending August 31, 2024 was $-0.307B, a 238.29% decline year-over-year.
  • Walgreens EBITDA for the twelve months ending August 31, 2024 was $-11.405B, a 160.86% increase year-over-year.
  • Walgreens 2024 annual EBITDA was $-11.405B, a 160.86% increase from 2023.
  • Walgreens 2023 annual EBITDA was $-4.372B, a 215.14% decline from 2022.
  • Walgreens 2022 annual EBITDA was $3.797B, a 19.55% increase from 2021.
Walgreens Annual EBITDA
(Millions of US $)
2024 $-11,405
2023 $-4,372
2022 $3,797
2021 $3,176
2020 $3,250
2019 $6,968
2018 $8,250
2017 $7,273
2016 $7,756
2015 $6,725
2014 $6,127
2013 $5,871
2012 $4,630
2011 $5,451
2010 $4,488
2009 $4,222
Walgreens Quarterly EBITDA
(Millions of US $)
2024-08-31 $-307
2024-05-31 $761
2024-02-29 $-12,478
2023-11-30 $619
2023-08-31 $222
2023-05-31 $179
2023-02-28 $831
2022-11-30 $-5,604
2022-08-31 $-246
2022-05-31 $285
2022-02-28 $1,874
2021-11-30 $1,884
2021-08-31 $1,486
2021-05-31 $1,738
2021-02-28 $1,385
2020-11-30 $-1,433
2020-08-31 $1,052
2020-05-31 $-962
2020-02-29 $1,657
2019-11-30 $1,503
2019-08-31 $1,230
2019-05-31 $1,708
2019-02-28 $2,101
2018-11-30 $1,929
2018-08-31 $1,915
2018-05-31 $2,091
2018-02-28 $2,621
2017-11-30 $1,623
2017-08-31 $1,443
2017-05-31 $2,014
2017-02-28 $1,933
2016-11-30 $1,883
2016-08-31 $1,621
2016-05-31 $1,983
2016-02-29 $2,302
2015-11-30 $1,850
2015-08-31 $1,314
2015-05-31 $1,839
2015-02-28 $1,985
2014-11-30 $1,587
2014-08-31 $1,539
2014-05-31 $1,497
2014-02-28 $1,684
2013-11-30 $1,407
2013-08-31 $1,782
2013-05-31 $1,440
2013-02-28 $1,627
2012-11-30 $1,022
2012-08-31 $896
2012-05-31 $1,169
2012-02-29 $1,388
2011-11-30 $1,177
2011-08-31 $1,554
2011-05-31 $1,220
2011-02-28 $1,463
2010-11-30 $1,214
2010-08-31 $1,008
2010-05-31 $1,092
2010-02-28 $1,334
2009-11-30 $1,054
2009-08-31 $936
2009-05-31 $1,110
2009-02-28 $1,271
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $7.168B $147.658B
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $70.181B 8.78
Herbalife (HLF) Cayman Islands $0.778B 4.11
China Jo-Jo Drugstores Holdings (CJJD) China $0.014B 0.00
GNC Holdings (GNC) United States $0.000B 0.00